A detailed history of Squarepoint Ops LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 15,706 shares of KRYS stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,706
Previous 2,408 552.24%
Holding current value
$2.49 Million
Previous $442,000 546.15%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$174.7 - $213.66 $2.32 Million - $2.84 Million
13,298 Added 552.24%
15,706 $2.86 Million
Q2 2024

Aug 14, 2024

BUY
$153.12 - $183.64 $368,712 - $442,205
2,408 New
2,408 $442,000
Q4 2023

Feb 14, 2024

BUY
$96.0 - $128.29 $356,064 - $475,827
3,709 New
3,709 $460,000
Q3 2022

Nov 14, 2022

BUY
$64.85 - $82.4 $539,552 - $685,568
8,320 New
8,320 $580,000
Q1 2022

May 16, 2022

SELL
$51.99 - $72.11 $1.13 Million - $1.57 Million
-21,794 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$39.81 - $88.24 $354,667 - $786,130
8,909 Added 69.14%
21,794 $1.52 Million
Q3 2021

Nov 15, 2021

BUY
$52.01 - $71.77 $436,051 - $601,719
8,384 Added 186.27%
12,885 $673,000
Q2 2021

Aug 16, 2021

BUY
$62.14 - $81.82 $279,692 - $368,271
4,501 New
4,501 $306,000
Q3 2020

Nov 16, 2020

SELL
$37.76 - $48.49 $217,422 - $279,205
-5,758 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$37.03 - $60.0 $213,218 - $345,480
5,758 New
5,758 $238,000
Q1 2020

May 15, 2020

SELL
$35.02 - $65.64 $411,905 - $772,057
-11,762 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$33.17 - $65.23 $668,275 - $1.31 Million
-20,147 Reduced 63.14%
11,762 $651,000
Q3 2019

Nov 14, 2019

SELL
$34.72 - $51.3 $261,059 - $385,724
-7,519 Reduced 19.07%
31,909 $1.11 Million
Q2 2019

Aug 14, 2019

BUY
$27.2 - $41.2 $891,534 - $1.35 Million
32,777 Added 492.81%
39,428 $1.59 Million
Q1 2019

May 15, 2019

BUY
$19.86 - $32.9 $132,088 - $218,817
6,651 New
6,651 $219,000
Q1 2018

May 15, 2018

SELL
$8.61 - $11.74 $92,988 - $126,792
-10,800 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$8.19 - $11.19 $88,452 - $120,852
10,800
10,800 $114,000

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.07B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.